HistCite - Chimerism and Transplantation topic search

Add FileX ?

Use wildcard '*' to add more than one file at a time. For example, if you have file1, file2, etc. all in the same folder or directory; first, locate one of the files with the [Browse...] button. Then alter the file path in the box above to include '*' character (eg. file*). Wildcard '?' to blanket only one character works too.
Note: In Windows you can select multiple files and "drag and drop" them onto HistCite icon or shortcut. The program would start and load those files.

#	Date / Author / Journal	LCS	GCS	LCR	CR
2004
5401	5401 Koehl U, Sorensen J, Esser R, Zimmermann S, Gruttner HP, et al. IL-2 activated NK cell immunotherapy of three children after haploidentical stem cell transplantation BLOOD CELLS MOLECULES AND DISEASES. 2004 NOV-DEC; 33 (3): 261-266	5	43	3	25
5402	5402 Obama K, Utsunomiya A, Takatsuka Y, Takemoto Y Reduced-intensity non-T-cell depleted HLA-haploidentical stem cell transplantation for older patients based on the concept of feto-maternal tolerance BONE MARROW TRANSPLANTATION. 2004 NOV; 34 (10): 897-899	6	19	4	12
5403	5403 Corti S, Locatelli F, Donadoni C, Guglieri M, Papadimitriou D, et al. Wild-type bone marrow cells ameliorate the phenotype of SOD1-G93A ALS mice and contribute to CNS, heart and skeletal muscle tissues BRAIN. 2004 NOV; 127: 2518-2532	3	88	6	37
5404	5404 Shimazaki C, Fuchida SI, Ochiai N, Nakano S, Yamada N, et al. Non-T-cell-depleted HLA-haploidentical stem cell transplantation after reduced-intensity conditioning in advanced haematological malignancies based on feto-maternal microchimerism BRITISH JOURNAL OF HAEMATOLOGY. 2004 NOV; 127 (4): 474-475	5	10	4	6
5405	5405 Shoji M, Sata M, Fukuda D, Tanaka K, Sato T, et al. Temporal and spatial characterization of cellular constituents during neointimal hyperplasia after vascular injury: Potential contribution of bone-marrow-derived progenitors to arterial remodeling CARDIOVASCULAR PATHOLOGY. 2004 NOV-DEC; 13 (6): 306-312	3	24	5	29
5406	5406 Camacho RE, Wnek R, Shah K, Zaller DM, O'Reilly RJ, et al. Intra-thymic/splenic engraftment of human T cells in HLA-DR1 transgenic NOD/scid mice CELLULAR IMMUNOLOGY. 2004 NOV-DEC; 232 (1-2): 86-95	0	7	5	32
5407	5407 Kong SY, Ki CS, Kim HJ, Lee KO, Bae JC, et al. Evaluation of imprecision for analysis of short tandem repeats by use of mixed blood cells in variable concentrations CLINICAL CHEMISTRY. 2004 NOV; 50 (11): 2193-2195	2	2	10	11
5408	5408 Borgatti M, Finotti A, Romanelli A, Saviano M, Bianchi N, et al. Peptide nucleic acids (PNA)-DNA chimeras targeting transcription factors as a tool to modify gene expression CURRENT DRUG TARGETS. 2004 NOV; 5 (8): 735-744	0	17	0	86
5409	5409 Rozemuller H, Knaan-Shanzer S, Hagenbeek A, van Bloois L, Storm G, et al. Enhanced engraftment of human cells in RAG2/gamma c double-knockout mice after treatment with CL2MDP liposomes EXPERIMENTAL HEMATOLOGY. 2004 NOV; 32 (11): 1118-1125	0	19	3	33
5410	5410 Bergeron A, Lettre F, Russo P, Morissette J, Tanguay RM No evidence of maternal cell colonization in reverted liver nodules of tyrosinemia type I patients GASTROENTEROLOGY. 2004 NOV; 127 (5): 1381-1385	0	1	2	28
#	Date / Author / Journal	LCS	GCS	LCR	CR
5411	5411 Narimatsu H, Morishita Y, Saito S, Shimada K, Ozeki K, et al. Conditioning regimen of melphalan, fludarabine and total body irradiation in unmanipulated HLA haploidentical stem cell transplantation based on feto-maternal tolerance INTERNAL MEDICINE. 2004 NOV; 43 (11): 1063-1067	3	6	10	21
5412	5412 Ferrant JL, Benjamin CD, Cutler AH, Kalled SL, Hsu YM, et al. The contribution of Fc effector mechanisms in the efficacy of anti-CD154 immunotherapy depends on the nature of the immune challenge INTERNATIONAL IMMUNOLOGY. 2004 NOV; 16 (11): 1583-1594	4	19	4	43
5413	5413 Yamada T, Tomonari A, Takahashi S, Ooi J, Iseki T, et al. Unrelated cord blood transplantation with a reduced-intensity conditioning regimen following autologous transplantation for multiple myeloma INTERNATIONAL JOURNAL OF HEMATOLOGY. 2004 NOV; 80 (4): 377-380	1	4	5	21
5414	5414 Rinkevich B Will two walk together, except they have agreed? Amos 3 : 3 JOURNAL OF EVOLUTIONARY BIOLOGY. 2004 NOV; 17 (6): 1178-1179	2	6	4	17
5415	5415 Sanchez-Fueyo A, Strom TB Immunological tolerance and liver transplantation JOURNAL OF HEPATOLOGY. 2004 NOV; 41 (5): 698-705	0	19	15	60
5416	5416 Smallshaw JE, Coleman E, Spiridon C, Vitetta ES The generation and anti-myeloma activity of a chimeric anti-CD54 antibody, cUV3 JOURNAL OF IMMUNOTHERAPY. 2004 NOV-DEC; 27 (6): 419-424	0	6	0	36
5417	5417 Land GA, Sellers R Chimeric DNA analysis for monitoring post bone marrow transplant patients JOURNAL OF MOLECULAR DIAGNOSTICS. 2004 NOV; 6 (4): 420-421	0	0	0	0
5418	5418 Wei Q, Dubie L, Lovell M Quantitative analysis of chimerism after bone marrow transplant by PCR amplification of STIR markers and capillary electrophoresis on beckman CEQ 8000 JOURNAL OF MOLECULAR DIAGNOSTICS. 2004 NOV; 6 (4): 436-436	0	0	0	0
5419	5419 Suemitsu R, Yoshino I, Shoji F, Yamaguchi M, Tomita Y, et al. The effects of pretreatment with donor antigen and immunosuppressive agents on fully allogenic tracheal graft JOURNAL OF SURGICAL RESEARCH. 2004 NOV; 122 (1): 8-13	0	3	5	29
5420	5420 Peters C Another step forward towards improved outcome after HLA-haploidentical stem cell transplantation LEUKEMIA. 2004 NOV; 18 (11): 1769-1771	0	4	11	28
#	Date / Author / Journal	LCS	GCS	LCR	CR
5421	5421 Choi SJ, Lee JH, Lee JH, Kim S, Seol M, et al. Treatment of relapsed acute myeloid leukemia after allogeneic bone marrow transplantation with chemotherapy followed by G-CSF-primed donor leukocyte infusion: a high incidence of isolated extramedullary relapse LEUKEMIA. 2004 NOV; 18 (11): 1789-1797	10	43	12	46
5422	5422 Passweg JR, Tichelli A, Meyer-Monard S, Heim D, Stern M, et al. Purified donor NK-lymphocyte infusion to consolidate engraftment after haploidentical stem cell transplantation LEUKEMIA. 2004 NOV; 18 (11): 1835-1838	5	73	3	16
5423	5423 Grassi A, Susca M, Ravaioli M, Grazi GL, D'Errico A, et al. Detection of recipient's cells in liver graft using antibodies to mismatched HLA class I antigens LIVER TRANSPLANTATION. 2004 NOV; 10 (11): 1406-1414	1	4	9	28
5424	5424 Stone JJ, Chang SH, Kimball PM, Stravitz RT, Fisher RA Living donor liver transplant with clinical tolerance, laboratory evidence of chimerism, and spontaneous clearance of HBV LIVER TRANSPLANTATION. 2004 NOV; 10 (11): 1432-1435	2	2	5	14
5425	5425 Laufs S, Nagy KZ, Giordano FA, Hotz-Wagenblatt A, Zeller WJ, et al. Insertion of retroviral vectors in NOD/SCID repopulating human peripheral blood progenitor cells occurs preferentially in the vicinity of transcription start regions and in introns MOLECULAR THERAPY. 2004 NOV; 10 (5): 874-881	0	59	1	45
5426	5426 Yahata T, Ando K, Miyatake H, Uno T, Sato T, et al. Competitive repopulation assay of two gene-marked cord blood units in NOD/SCID gamma c(null) mice MOLECULAR THERAPY. 2004 NOV; 10 (5): 882-891	3	14	6	32
5427	5427 Aversa F, Martelli MF Transplantation of haploidentically mismatched stem cells for the treatment of malignant diseases SPRINGER SEMINARS IN IMMUNOPATHOLOGY. 2004 NOV; 26 (1-2): 155-168	5	17	13	73
5428	5428 Prigozhina T, Slavin S Transplantation of hematopoietic stem cells for induction of unresponsiveness to organ allografts SPRINGER SEMINARS IN IMMUNOPATHOLOGY. 2004 NOV; 26 (1-2): 169-185	2	3	44	110
5429	5429 Yang YG Application of xenogeneic stem cells for induction of transplantation tolerance: present state and future directions SPRINGER SEMINARS IN IMMUNOPATHOLOGY. 2004 NOV; 26 (1-2): 187-200	5	14	22	80
5430	5430 Baertschiger RM, Buhler LH Xenotransplantation literature update July-August, 2004 XENOTRANSPLANTATION. 2004 NOV; 11 (6): 559-562	0	0	4	32
#	Date / Author / Journal	LCS	GCS	LCR	CR
5431	5431 Colson YL, Xu H, Huang YM, Ildsta ST Mixed xenogeneic chimerism induces donor-specific humoral and cellular immune tolerance for cardiac xenografts JOURNAL OF IMMUNOLOGY. 2004 NOV 1; 173 (9): 5827-5834	7	9	13	41
5432	5432 Chou J, Mackman N, Merrill-Skoloff G, Pedersen B, Furie BC, et al. Hematopoietic cell-derived microparticle tissue factor contributes to fibrin formation during thrombus propagation BLOOD. 2004 NOV 15; 104 (10): 3190-3197	2	165	0	34
5433	5433 Zou LH, Barnett B, Safah H, LaRussa VF, Evdemon-Hogan M, et al. Bone marrow is a reservoir for CD4(+)CD25(+) regulatory T cells that traffic through CXCL12/CXCR4 signals CANCER RESEARCH. 2004 NOV 15; 64 (22): 8451-8455	1	110	1	33
5434	5434 Moustafa ME, Srivastava AS, Nedelcu E, Donahue J, Gueorguieva I, et al. Chimerism and tolerance post-in utero transplantation with embryonic stem cells TRANSPLANTATION. 2004 NOV 15; 78 (9): 1274-1282	2	4	13	30
5435	5435 Anam K, Akpinar E, Craighead N, Black AT, Hale DA Targeted T-cell depletion or CD154 blockade generates mixed hemopoietic chimerism and donor-specific tolerance in mice treated with sirolimus and donor bone marrow TRANSPLANTATION. 2004 NOV 15; 78 (9): 1290-1298	8	11	13	33
5436	5436 Westerhuis G, Maas WG, Willemze R, Toes RE, Fibbe WE Hematopoietic chimerism following non-myeoloablative stem cell transplantation is dependent on NK cell tolerance. BLOOD. 2004 NOV 16; 104 (11): 16A-17A	0	0	0	0
5437	5437 Alyea EP, Li SL, Kim H, Ho VT, Cutler C, et al. High levels of donor chimerism early after non-myeloablative transplantation predictive of overall and progression free survival but not risk of acute graft versus host disease for patients with AML or MDS. BLOOD. 2004 NOV 16; 104 (11): 57A-57A	0	0	0	0
5438	5438 Sandmaier BM, Maloney DG, Maris MB, Chauncey TR, Pulsipher M, et al. Conversion of low donor chimerism following nonmyeloablative conditioning for hematopoietic cell transplantation (HCT) using Pentostatin and donor lymphocyte infusion (DLI). BLOOD. 2004 NOV 16; 104 (11): 57A-57A	5	6	0	0
5439	5439 Cho SG, Shuto Y, Soda Y, Nakazaki Y, Izawa K, et al. Anti-NK cell treatment induces stable mixed chimerism in MHC-mismatched, T-cell depleted, nonmyeloablative bone marrow transplantation. BLOOD. 2004 NOV 16; 104 (11): 316B-316B	0	0	0	0
5440	5440 Dennison JD, Al Zadjali S, Tauro M, Al Kindi S, Muralitharan S, et al. Suboptimal busulphan exposure is associated with mixed hematopoietic chimerism, a risk factor for rejection in bone marrow transplantation for homozygous beta thalassemia BLOOD. 2004 NOV 16; 104 (11): 325A-326A	0	0	0	0
#	Date / Author / Journal	LCS	GCS	LCR	CR
5441	5441 Kojima R, Heike Y, Narumi J, Yamagata S, Chizuka A, et al. Analysis of chimerism induction following allogeneic hematopoietic stem cell transplantation (HSCT) with a reduced-intensity regimen. BLOOD. 2004 NOV 16; 104 (11): 339B-339B	0	0	0	0
5442	5442 Diaconescu R, Leisenring W, Kahl C, Sorror M, Zellmer E, et al. Marrow allografts after nonmyeloablative conditioning: Effect of cell dose on rejection and degree of donor chimerism. BLOOD. 2004 NOV 16; 104 (11): 340A-340A	0	0	0	0
5443	5443 Zeiser R, Spyridonidis A, Waesch R, Bertz H, Finke J Comparison of gel versus capillary electrophoresis for chimerism monitoring by PCR amplification of microsatellite markers after allogeneic hematopoietic cell transplantation. BLOOD. 2004 NOV 16; 104 (11): 360B-361B	0	0	0	0
5444	5444 Nava P, Simon A, Gonzalez-Pardo G, Jimenez JL, Gonzalez-Rivera M, et al. Anticipated diagnosis of adverse events after stem cell transplantation using highly sensitive STR-PCR for chimerism quantification. BLOOD. 2004 NOV 16; 104 (11): 361B-361B	0	0	0	0
5445	5445 Ma SY, Au WY, Lei AKW, Tse E, Chim CS, et al. Full donor chimerism in both plasma and mononuclear cell after haematopoietic stem cell transplant (HSCT) at D28 is predictive of acute graft-versus-host disease but not disease relapse or graft failure. BLOOD. 2004 NOV 16; 104 (11): 362B-362B	0	0	0	0
5446	5446 Tang XW, Wu DP, Sun AN, Zhu ZL, Chang HR, et al. The application of sequential and quantitative analysis of donor chimerism in adoptive immunotherapy following allogeneic stem cell transplantation. BLOOD. 2004 NOV 16; 104 (11): 363B-363B	0	0	0	0
5447	5447 Yoshihara T, Morimoto A, Kuroda H, Ishida H, Imamura T, et al. Clinical status longer than one year post-transplantation in 4 recipients of non-T-cell-depleted HLA-haploidentical transplantation based on feto-maternal microchimerism. BLOOD. 2004 NOV 16; 104 (11): 375B-375B	0	0	0	0
5448	5448 Zeiser R, Spyridonidis A, Waesch R, Ihorst G, Grullich C, et al. Comparison of conventional versus lineage-specific chimerism analysis for detection of minimal residual disease or relapse in myeloid malignancies after myeloablative allogeneic hematopoietic cell transplantation with respect to clinical follow-up. BLOOD. 2004 NOV 16; 104 (11): 456A-456A	0	0	0	0
5449	5449 Wu CJ, Gladwin MT, Krishnamurti L, Biernacki M, Rogers SA, et al. Mixed chimerism following nonmyeloablative stem cell transplantation for sickle cell disease prevents intravascular hemolysis and restores endothelial function. BLOOD. 2004 NOV 16; 104 (11): 467A-467A	0	0	0	0
5450	5450 Michallet M, Le QH, Michallet AS, Nicolini FE, Thiebaut A, et al. Kinetics of chimerism conversion to total donor profile: Impact on transplant outcome after reduced intensity conditioning allogeneic transplantation. BLOOD. 2004 NOV 16; 104 (11): 504A-504A	0	0	0	0
#	Date / Author / Journal	LCS	GCS	LCR	CR
5451	5451 Kahl C, Mielcarek M, Iwata M, Harkey M, Storer B, et al. Radiation dose determines degree of donor chimerism after nonmyeloablative hematopoietic cell transplantation. BLOOD. 2004 NOV 16; 104 (11): 506A-506A	0	0	0	0
5452	5452 Burt RK, Verda L, Kim DA, Statkute L, Oyama Y, et al. Embryonic stem cell transplant (ESCT)-derived mixed hematopoietic chimerism prevents diabetes in NOD mice. BLOOD. 2004 NOV 16; 104 (11): 587A-587A	0	0	0	1
5453	5453 Spyridonidis A, Metaxas Y, Zeiser R, Waterhouse M, Faber P, et al. Allogeneic hematopoietic stem cell transplantation (HSCT) is followed by epithelial chimerism of the oral mucosal BLOOD. 2004 NOV 16; 104 (11): 737A-737A	0	0	0	0
5454	5454 Baron F, Maris M, Storer B, Sandmaier B, Panse J, et al. Higher doses of transplanted CD34+, CD3+ and CD8+ cells are associated with better donor T-cell chimerism and less graft rejection, but not with GVHD after nonmyeloablative conditioning for unrelated hematopoietic cell transplantation. BLOOD. 2004 NOV 16; 104 (11): 753A-753A	0	0	0	0
5455	5455 Kaltwasser M, Lehne M, Wajant H, Huber C, Hartwig UF Separation of GvH- and GvL-Immune responses in allogeneic stem cell transplantation by CD95-mediated depletion of alloreactive T-cells using CD178 based proapoptotic chimeric molecules. BLOOD. 2004 NOV 16; 104 (11): 834A-834A	0	0	0	0
5456	5456 Sokolic RA, Gu YC, Burkholder T, Tuschong LM, Hai M, et al. Non-myeloablative conditioning with busulfan prior to allogeneic hematopoietic stem cell transplant results in mixed chimerism and reversal of the phenotype in canine leukocyte adhesion deficiency with minimal regimen related toxicity and without graft-vs.-host disease. BLOOD. 2004 NOV 16; 104 (11): 837A-837A	0	0	0	0
5457	5457 Bailo M, Soncini M, Vertua E, Signoroni PB, Sanzone S, et al. Engraftment potential of human amnion and chorion cells derived from term placenta TRANSPLANTATION. 2004 NOV 27; 78 (10): 1439-1448	6	87	3	41
5458	5458 Jiang SG, Walker L, Afentoulis M, Anderson DA, Jauron-Mills L, et al. Transplanted human bone marrow contributes to vascular endothelium PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2004 NOV 30; 101 (48): 16891-16896	11	76	14	45
5459	5459 Petersen S, Gendelman M, Murphy K, Torbenson M, Jones R, et al. Microchimerism following canine in utero hematopoietic stem cell transplantation: Development of T-cell dosing regimens AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY. 2004 DEC; 191 (6): S15-S15	0	0	0	0
5460	5460 Mengel M, Jonigk D, Wilkens L, Radermacher J, von Wasielewski R, et al. Chimerism of metanephric adenoma but not of carcinoma in kidney transplants AMERICAN JOURNAL OF PATHOLOGY. 2004 DEC; 165 (6): 2079-2085	3	7	11	36
#	Date / Author / Journal	LCS	GCS	LCR	CR
5461	5461 Simpson E Reminiscences of Sir Peter Medawar: In hope of antigen-specific transplantation tolerance AMERICAN JOURNAL OF TRANSPLANTATION. 2004 DEC; 4 (12): 1937-1940	0	2	3	29
5462	5462 Blaney JE, Hanson CT, Firestone CY, Hanley KA, Murphy BR, et al. Genetically modified, live attenuated dengue virus type 3 vaccine candidates AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE. 2004 DEC; 71 (6): 811-821	1	46	0	47
5463	5463 Febbraio M, Guy E, Silverstein RL Stem cell transplantation reveals that absence of macrophage CD36 is protective against atherosclerosis ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY. 2004 DEC; 24 (12): 2333-2338	0	65	0	32
5464	5464 Kabl C, Mielcarek M, Iwata M, Harkey MA, Storer B, et al. Radiation dose determines the degree of myeloid engraftment after nonmyeloablative stem cell transplantation BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION. 2004 DEC; 10 (12): 826-833	0	0	8	25
5465	5465 Thompson JS, Pomeroy C, Kryscio RJ, Brown SA, Reece D, et al. Use of a T cell-specific monoclonal antibody, T10B9, in a novel allogeneic stem cell transplantation protocol for hematologic malignancy high-risk patients BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION. 2004 DEC; 10 (12): 858-866	2	16	15	44
5466	5466 Gupta V, Ball SE, Yi QL, Sage D, McCann SR, et al. Favorable effect on acute and chronic graft-versus-host disease with cyclophosphamide and in vivo anti-CD52 monoclonal antibodies for marrow transplantation from HLA-identical sibling donors for acquired aplastic anemia BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION. 2004 DEC; 10 (12): 867-876	6	29	6	44
5467	5467 Mohr B, Koch R, Thiede C, Kroschinsky F, Ehninger G, et al. CD34+ cell dose, conditioning regimen and prior chemotherapy: factors with significant impact on the early kinetics of donor chimerism after allogeneic hematopoietic cell transplantation BONE MARROW TRANSPLANTATION. 2004 DEC; 34 (11): 949-954	2	7	19	25
5468	5468 Au WY, Chan EC, Pang A, Lie AKW, Liang R, et al. Nonhematologic malignancies after allogeneic hematopoietic stem cell transplantation: incidence and molecular monitoring BONE MARROW TRANSPLANTATION. 2004 DEC; 34 (11): 981-985	3	12	0	20
5469	5469 Ho VT, Kim HT, Li S, Hochberg EP, Cutler C, et al. Partial CD8+ T-cell depletion of allogeneic peripheral blood stem cell transplantation is insufficient to prevent graft-versus-host disease BONE MARROW TRANSPLANTATION. 2004 DEC; 34 (11): 987-994	2	15	9	31
5470	5470 Passweg JR, Orchard K, Buergi A, Gratwohl A, Powles R, et al. Autologous/syngeneic stem cell transplantation to treat refractory GvHD BONE MARROW TRANSPLANTATION. 2004 DEC; 34 (11): 995-998	1	6	4	15
#	Date / Author / Journal	LCS	GCS	LCR	CR
5471	5471 Alessandrino EP, Bernasconi P, Colombo AA, Caldera D, Malcovati L, et al. Reduced-intensity conditioning regimen with thiotepa and fludarabine followed by allogeneic blood stem cell transplantation in haematological malignancies BONE MARROW TRANSPLANTATION. 2004 DEC; 34 (12): 1039-1045	0	4	12	28
5472	5472 Koldehoff M, Beelen DW, Trenschel R, Steckel NK, Peceny R, et al. Outcome of hematopoietic stem cell transplantation in patients with atypical chronic myeloid leukemia BONE MARROW TRANSPLANTATION. 2004 DEC; 34 (12): 1047-1050	1	2	3	21
5473	5473 Matsuda K, Yamauchi K, Tozuka M, Suzuki T, Sugano M, et al. Monitoring of hematopoietic chimerism by short tandem repeats, and the effect of CD selection on its sensitivity CLINICAL CHEMISTRY. 2004 DEC; 50 (12): 2411-2414	1	5	12	23
5474	5474 Walshe J, Bishop MR Factors affecting engraftment of allogeneic hematopoietic stem cells after reduced-intensity conditioning CYTOTHERAPY. 2004 DEC; 6 (6): 589-592	2	5	16	23
5475	5475 Cho SG, Shuto Y, Soda Y, Nakazaki Y, Izawa K, et al. Anti-NK cell treatment induces stable mixed chimerism in MHC-mismatched, T cell-depleted, nonmyeloablative bone marrow transplantation EXPERIMENTAL HEMATOLOGY. 2004 DEC; 32 (12): 1246-1254	7	8	11	29
5476	5476 Goebel WS, Pech NK, Meyers JL, Srour EF, Yoder MC, et al. A murine model of antimetabolite-based, submyeloablative conditioning for bone marrow transplantation: biologic insights and potential applications EXPERIMENTAL HEMATOLOGY. 2004 DEC; 32 (12): 1255-1264	1	9	8	44
5477	5477 Villaron EM, Almeida J, Lopez-Holgado N, Alcoceba M, Sanchez-Abarca LI, et al. Mesenchymal stem cells are present in peripheral blood and can engraft after allogeneic hematopoietic stem cell transplantation HAEMATOLOGICA. 2004 DEC; 89 (12): 1421-1427	6	47	4	30
5478	5478 Kai T, Kimura H, Shiga Y, Mineishi S, Yoshihara S, et al. Philadelphia chromosome-positive acute lymphoblastic leukemia rescued with a second allogeneic stem cell transplantation from a haploidentical mother after relapse following cord blood transplantation INTERNATIONAL JOURNAL OF HEMATOLOGY. 2004 DEC; 80 (5): 453-457	0	1	8	18
5479	5479 Toubo T, Suga N, Ohga S, Nomura A, Onoe Y, et al. Successful unrelated cord blood transplantation for Epstein-Barr virus-associated lymphoproliferative disease with hemophagocytic syndrome INTERNATIONAL JOURNAL OF HEMATOLOGY. 2004 DEC; 80 (5): 458-462	2	7	0	29
5480	5480 Tanaka T, Matsubara H, Adachi S, Chang H, Fujino H, et al. Second transplantation from HLA 2-loci-mismatched mother for graft failure due to hemophagocytic syndrome after cord blood transplantation INTERNATIONAL JOURNAL OF HEMATOLOGY. 2004 DEC; 80 (5): 467-469	1	10	3	8
#	Date / Author / Journal	LCS	GCS	LCR	CR
5481	5481 Sonnenday CJ, Warren DS, Cooke SK, Dietz HC, Montgomery RA A novel chimeric ribozyme vector produces potent inhibition of ICAM-1 expression on ischemic vascular endothelium JOURNAL OF GENE MEDICINE. 2004 DEC; 6 (12): 1394-1402	0	6	0	33
5482	5482 Khorshid O, Hosing C, Bibawi S, Ueno N, Reveille J, et al. Nonmyeloablative stem cell transplant in a patient with advanced systemic sclerosis and systemic lupus erythematosus JOURNAL OF RHEUMATOLOGY. 2004 DEC; 31 (12): 2513-2516	6	27	10	31
5483	5483 Doyle AM, Lechler RI, Turka LA Organ transplantation: Halfway through the first century JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. 2004 DEC; 15 (12): 2965-2971	0	8	4	34
5484	5484 Stevens AM, McDonnell WM, Mullarkey ME, Pang JM, Leisenring W, et al. Liver biopsies from human females contain male hepatocytes in the absence of transplantation LABORATORY INVESTIGATION. 2004 DEC; 84 (12): 1603-1609	20	34	11	36
5485	5485 Scheffold C, Kroeger M, Zuehlsdorf M, Tchinda J, Silling G, et al. Prediction of relapse of acute myeloid leukemia in allogeneic transplant recipients by marrow CD34+donor cell chimerism analysis LEUKEMIA. 2004 DEC; 18 (12): 2048-2050	3	6	6	8
5486	5486 Subklewe M, Nagy M, Schoch C, Jenisch S, Siebert R, et al. Extramedullary manifestation of a donor-derived acute myeloid leukemia in a liver transplant patient LEUKEMIA. 2004 DEC; 18 (12): 2050-2053	1	2	2	8
5487	5487 Miyakoshi S, Kami M, Kishi Y, Murashige N, Yuji K, et al. Fatal hepatic failure associated with graft rejection following reduced-intensity stem-cell transplantation for chronic idiopathic myelofibrosis (CIMF) LEUKEMIA & LYMPHOMA. 2004 DEC; 45 (12): 2513-2516	0	0	3	11
5488	5488 Demir Y, Ozmen S, Klimczak A, Mukherjee AL, Siemionow M Tolerance induction in composite facial allograft transplantation in the rat model PLASTIC AND RECONSTRUCTIVE SURGERY. 2004 DEC; 114 (7): 1790-1801	14	58	1	24
5489	5489 Van de Wiele C, Revets H, Mertens N Radioimmunoimaging - Advances and prospects QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING. 2004 DEC; 48 (4): 317-325	0	16	1	49
5490	5490 Schoeberlein A, Schatt S, Troeger C, Surbek D, Holzgreve W, et al. Engraftment kinetics of human cord blood and murine fetal liver stem cells following in utero transplantation into immunodeficient mice STEM CELLS AND DEVELOPMENT. 2004 DEC; 13 (6): 677-684	4	12	7	24
#	Date / Author / Journal	LCS	GCS	LCR	CR
5491	5491 Burkhart C, Heusser C, Morris RE, Raulf F, Weckbecker G, et al. Pharmacodynamics in the development of new immunosuppressive drugs THERAPEUTIC DRUG MONITORING. 2004 DEC; 26 (6): 588-592	0	12	0	49
5492	5492 Flesland O, Ip LSK, Storlien AS, Spurkland A, Larsen J, et al. Microchimerism in immune competent patients related to the leukocyte content of transfused red blood cell concentrates TRANSFUSION AND APHERESIS SCIENCE. 2004 DEC; 31 (3): 173-180	1	1	8	36
5493	5493 Chen J, He QZ, Xu HB, Su LP, Zhang JP, et al. The CD28 peptidemimic can induce mixed chimerism and prolong the survival of cardiac allografts TRANSPLANT IMMUNOLOGY. 2004 DEC; 13 (4): 283-288	3	3	16	34
5494	5494 Tsutsumi Y, Tanaka J, Minami H, Musashi M, Fukushima A, et al. Monitoring of T-cell repertoire was useful for predicting graft-versus-host disease prognosis in a patient with chronic myelogeneous leukemia after allogeneic bone marrow transplantation TRANSPLANTATION PROCEEDINGS. 2004 DEC; 36 (10): 3200-3202	0	0	4	5
5495	5495 Kanatani T, Wright B, Lanzetta M, Molitor M, McCaughan GW, et al. Experimental limb transplantation, Part III: Induction of tolerance in the rigorous strain combination of Brown Norway donor to Lewis recipient TRANSPLANTATION PROCEEDINGS. 2004 DEC; 36 (10): 3276-3282	2	3	8	31
5496	5496 Ichinohe T, Uchiyama T, Shimazaki C, Matsuo K, Tamaki S, et al. Feasibility of HLA-haploidentical hematopoletic stem cell transplantation between noninherited maternal antigen (NIMA)-mismatched family members linked with long-term fetomatemal microchimerism BLOOD. 2004 DEC 1; 104 (12): 3821-3828	32	62	20	58
5497	5497 Tykodi SS, Warren EH, Thompson JA, Riddell SR, Childs RW, et al. Allogeneic hematopoietic cell transplantation for metastatic renal cell carcinoma after nonmyeloablative conditioning: Toxicity, clinical response, and immunological response to minor histocompatibility antigens CLINICAL CANCER RESEARCH. 2004 DEC 1; 10 (23): 7799-7811	14	62	9	65
5498	5498 Metzler B, Gfeller P, Bigaud M, Li JP, Wieczorek G, et al. Combinations of anti-LFA-1, everolimus, anti-CD40 ligand, and allogeneic bone marrow induce central transplantation tolerance through hemopoietic chimerism, including protection from chronic heart allograft rejection JOURNAL OF IMMUNOLOGY. 2004 DEC 1; 173 (11): 7025-7036	9	23	29	72
5499	5499 Morris E, Thomson K, Craddock C, Mahendra P, Milligan D, et al. Outcomes after alemtuzumab-containing reduced-intensity allogeneic transplantation regimen for relapsed and refractory non-Hodgkin lymphoma BLOOD. 2004 DEC 15; 104 (13): 3865-3871	14	171	10	27
5500	5500 Krause DS, Van Etten RA Adoptive immunotherapy of BCR-ABL-induced chronic myeloid leukemia-like myeloproliferative disease in a murine model BLOOD. 2004 DEC 15; 104 (13): 4236-4244	0	4	13	34

Date / Author / Journal

LCS

GCS

LCR

2004

5401

5401 Koehl U, Sorensen J, Esser R, Zimmermann S, Gruttner HP, et al.

IL-2 activated NK cell immunotherapy of three children after haploidentical stem cell transplantation

BLOOD CELLS MOLECULES AND DISEASES. 2004 NOV-DEC; 33 (3): 261-266

5402

5402 Obama K, Utsunomiya A, Takatsuka Y, Takemoto Y

Reduced-intensity non-T-cell depleted HLA-haploidentical stem cell transplantation for older patients based on the concept of feto-maternal tolerance

BONE MARROW TRANSPLANTATION. 2004 NOV; 34 (10): 897-899

5403

5403 Corti S, Locatelli F, Donadoni C, Guglieri M, Papadimitriou D, et al.

Wild-type bone marrow cells ameliorate the phenotype of SOD1-G93A ALS mice and contribute to CNS, heart and skeletal muscle tissues

BRAIN. 2004 NOV; 127: 2518-2532

5404

5404 Shimazaki C, Fuchida SI, Ochiai N, Nakano S, Yamada N, et al.

Non-T-cell-depleted HLA-haploidentical stem cell transplantation after reduced-intensity conditioning in advanced haematological malignancies based on feto-maternal microchimerism

BRITISH JOURNAL OF HAEMATOLOGY. 2004 NOV; 127 (4): 474-475

5405

5405 Shoji M, Sata M, Fukuda D, Tanaka K, Sato T, et al.

Temporal and spatial characterization of cellular constituents during neointimal hyperplasia after vascular injury: Potential contribution of bone-marrow-derived progenitors to arterial remodeling

CARDIOVASCULAR PATHOLOGY. 2004 NOV-DEC; 13 (6): 306-312

5406

5406 Camacho RE, Wnek R, Shah K, Zaller DM, O'Reilly RJ, et al.

Intra-thymic/splenic engraftment of human T cells in HLA-DR1 transgenic NOD/scid mice

CELLULAR IMMUNOLOGY. 2004 NOV-DEC; 232 (1-2): 86-95

5407

5407 Kong SY, Ki CS, Kim HJ, Lee KO, Bae JC, et al.

Evaluation of imprecision for analysis of short tandem repeats by use of mixed blood cells in variable concentrations

CLINICAL CHEMISTRY. 2004 NOV; 50 (11): 2193-2195

5408

5408 Borgatti M, Finotti A, Romanelli A, Saviano M, Bianchi N, et al.

Peptide nucleic acids (PNA)-DNA chimeras targeting transcription factors as a tool to modify gene expression

CURRENT DRUG TARGETS. 2004 NOV; 5 (8): 735-744

5409

5409 Rozemuller H, Knaan-Shanzer S, Hagenbeek A, van Bloois L, Storm G, et al.

Enhanced engraftment of human cells in RAG2/gamma c double-knockout mice after treatment with CL2MDP liposomes

EXPERIMENTAL HEMATOLOGY. 2004 NOV; 32 (11): 1118-1125

5410

5410 Bergeron A, Lettre F, Russo P, Morissette J, Tanguay RM

No evidence of maternal cell colonization in reverted liver nodules of tyrosinemia type I patients

GASTROENTEROLOGY. 2004 NOV; 127 (5): 1381-1385

Date / Author / Journal

LCS

GCS

LCR

5411

5411 Narimatsu H, Morishita Y, Saito S, Shimada K, Ozeki K, et al.

Conditioning regimen of melphalan, fludarabine and total body irradiation in unmanipulated HLA haploidentical stem cell transplantation based on feto-maternal tolerance

INTERNAL MEDICINE. 2004 NOV; 43 (11): 1063-1067

5412

5412 Ferrant JL, Benjamin CD, Cutler AH, Kalled SL, Hsu YM, et al.

The contribution of Fc effector mechanisms in the efficacy of anti-CD154 immunotherapy depends on the nature of the immune challenge

INTERNATIONAL IMMUNOLOGY. 2004 NOV; 16 (11): 1583-1594

5413

5413 Yamada T, Tomonari A, Takahashi S, Ooi J, Iseki T, et al.

INTERNATIONAL JOURNAL OF HEMATOLOGY. 2004 NOV; 80 (4): 377-380

5414

5414 Rinkevich B

Will two walk together, except they have agreed? Amos 3 : 3

JOURNAL OF EVOLUTIONARY BIOLOGY. 2004 NOV; 17 (6): 1178-1179

5415

5415 Sanchez-Fueyo A, Strom TB

Immunological tolerance and liver transplantation

JOURNAL OF HEPATOLOGY. 2004 NOV; 41 (5): 698-705

5416

5416 Smallshaw JE, Coleman E, Spiridon C, Vitetta ES

The generation and anti-myeloma activity of a chimeric anti-CD54 antibody, cUV3

JOURNAL OF IMMUNOTHERAPY. 2004 NOV-DEC; 27 (6): 419-424

5417

5417 Land GA, Sellers R

Chimeric DNA analysis for monitoring post bone marrow transplant patients

JOURNAL OF MOLECULAR DIAGNOSTICS. 2004 NOV; 6 (4): 420-421

5418

5418 Wei Q, Dubie L, Lovell M

Quantitative analysis of chimerism after bone marrow transplant by PCR amplification of STIR markers and capillary electrophoresis on beckman CEQ 8000

JOURNAL OF MOLECULAR DIAGNOSTICS. 2004 NOV; 6 (4): 436-436

5419

5419 Suemitsu R, Yoshino I, Shoji F, Yamaguchi M, Tomita Y, et al.

The effects of pretreatment with donor antigen and immunosuppressive agents on fully allogenic tracheal graft

JOURNAL OF SURGICAL RESEARCH. 2004 NOV; 122 (1): 8-13

5420

5420 Peters C

Another step forward towards improved outcome after HLA-haploidentical stem cell transplantation

LEUKEMIA. 2004 NOV; 18 (11): 1769-1771

Date / Author / Journal

LCS

GCS

LCR

5421

5421 Choi SJ, Lee JH, Lee JH, Kim S, Seol M, et al.

Treatment of relapsed acute myeloid leukemia after allogeneic bone marrow transplantation with chemotherapy followed by G-CSF-primed donor leukocyte infusion: a high incidence of isolated extramedullary relapse

LEUKEMIA. 2004 NOV; 18 (11): 1789-1797

5422

5422 Passweg JR, Tichelli A, Meyer-Monard S, Heim D, Stern M, et al.

Purified donor NK-lymphocyte infusion to consolidate engraftment after haploidentical stem cell transplantation

LEUKEMIA. 2004 NOV; 18 (11): 1835-1838

5423

5423 Grassi A, Susca M, Ravaioli M, Grazi GL, D'Errico A, et al.

Detection of recipient's cells in liver graft using antibodies to mismatched HLA class I antigens

LIVER TRANSPLANTATION. 2004 NOV; 10 (11): 1406-1414

5424

5424 Stone JJ, Chang SH, Kimball PM, Stravitz RT, Fisher RA

Living donor liver transplant with clinical tolerance, laboratory evidence of chimerism, and spontaneous clearance of HBV

LIVER TRANSPLANTATION. 2004 NOV; 10 (11): 1432-1435

5425

5425 Laufs S, Nagy KZ, Giordano FA, Hotz-Wagenblatt A, Zeller WJ, et al.

Insertion of retroviral vectors in NOD/SCID repopulating human peripheral blood progenitor cells occurs preferentially in the vicinity of transcription start regions and in introns

MOLECULAR THERAPY. 2004 NOV; 10 (5): 874-881

5426

5426 Yahata T, Ando K, Miyatake H, Uno T, Sato T, et al.

Competitive repopulation assay of two gene-marked cord blood units in NOD/SCID gamma c(null) mice

MOLECULAR THERAPY. 2004 NOV; 10 (5): 882-891

5427

5427 Aversa F, Martelli MF

Transplantation of haploidentically mismatched stem cells for the treatment of malignant diseases

SPRINGER SEMINARS IN IMMUNOPATHOLOGY. 2004 NOV; 26 (1-2): 155-168

5428

5428 Prigozhina T, Slavin S

Transplantation of hematopoietic stem cells for induction of unresponsiveness to organ allografts

SPRINGER SEMINARS IN IMMUNOPATHOLOGY. 2004 NOV; 26 (1-2): 169-185

110

5429

5429 Yang YG

Application of xenogeneic stem cells for induction of transplantation tolerance: present state and future directions

SPRINGER SEMINARS IN IMMUNOPATHOLOGY. 2004 NOV; 26 (1-2): 187-200

5430

5430 Baertschiger RM, Buhler LH

Xenotransplantation literature update July-August, 2004

XENOTRANSPLANTATION. 2004 NOV; 11 (6): 559-562

Date / Author / Journal

LCS

GCS

LCR

5431

5431 Colson YL, Xu H, Huang YM, Ildsta ST

Mixed xenogeneic chimerism induces donor-specific humoral and cellular immune tolerance for cardiac xenografts

JOURNAL OF IMMUNOLOGY. 2004 NOV 1; 173 (9): 5827-5834

5432

5432 Chou J, Mackman N, Merrill-Skoloff G, Pedersen B, Furie BC, et al.

Hematopoietic cell-derived microparticle tissue factor contributes to fibrin formation during thrombus propagation

BLOOD. 2004 NOV 15; 104 (10): 3190-3197

165

5433

5433 Zou LH, Barnett B, Safah H, LaRussa VF, Evdemon-Hogan M, et al.

Bone marrow is a reservoir for CD4(+)CD25(+) regulatory T cells that traffic through CXCL12/CXCR4 signals

CANCER RESEARCH. 2004 NOV 15; 64 (22): 8451-8455

110

5434

5434 Moustafa ME, Srivastava AS, Nedelcu E, Donahue J, Gueorguieva I, et al.

Chimerism and tolerance post-in utero transplantation with embryonic stem cells

TRANSPLANTATION. 2004 NOV 15; 78 (9): 1274-1282

5435

5435 Anam K, Akpinar E, Craighead N, Black AT, Hale DA

Targeted T-cell depletion or CD154 blockade generates mixed hemopoietic chimerism and donor-specific tolerance in mice treated with sirolimus and donor bone marrow

TRANSPLANTATION. 2004 NOV 15; 78 (9): 1290-1298

5436

5436 Westerhuis G, Maas WG, Willemze R, Toes RE, Fibbe WE

Hematopoietic chimerism following non-myeoloablative stem cell transplantation is dependent on NK cell tolerance.

BLOOD. 2004 NOV 16; 104 (11): 16A-17A

5437

5437 Alyea EP, Li SL, Kim H, Ho VT, Cutler C, et al.

High levels of donor chimerism early after non-myeloablative transplantation predictive of overall and progression free survival but not risk of acute graft versus host disease for patients with AML or MDS.

BLOOD. 2004 NOV 16; 104 (11): 57A-57A

5438

5438 Sandmaier BM, Maloney DG, Maris MB, Chauncey TR, Pulsipher M, et al.

Conversion of low donor chimerism following nonmyeloablative conditioning for hematopoietic cell transplantation (HCT) using Pentostatin and donor lymphocyte infusion (DLI).

BLOOD. 2004 NOV 16; 104 (11): 57A-57A

5439

5439 Cho SG, Shuto Y, Soda Y, Nakazaki Y, Izawa K, et al.

Anti-NK cell treatment induces stable mixed chimerism in MHC-mismatched, T-cell depleted, nonmyeloablative bone marrow transplantation.

BLOOD. 2004 NOV 16; 104 (11): 316B-316B

5440

5440 Dennison JD, Al Zadjali S, Tauro M, Al Kindi S, Muralitharan S, et al.

Suboptimal busulphan exposure is associated with mixed hematopoietic chimerism, a risk factor for rejection in bone marrow transplantation for homozygous beta thalassemia

BLOOD. 2004 NOV 16; 104 (11): 325A-326A

Date / Author / Journal

LCS

GCS

LCR

5441

5441 Kojima R, Heike Y, Narumi J, Yamagata S, Chizuka A, et al.

Analysis of chimerism induction following allogeneic hematopoietic stem cell transplantation (HSCT) with a reduced-intensity regimen.

BLOOD. 2004 NOV 16; 104 (11): 339B-339B

5442

5442 Diaconescu R, Leisenring W, Kahl C, Sorror M, Zellmer E, et al.

Marrow allografts after nonmyeloablative conditioning: Effect of cell dose on rejection and degree of donor chimerism.

BLOOD. 2004 NOV 16; 104 (11): 340A-340A

5443

5443 Zeiser R, Spyridonidis A, Waesch R, Bertz H, Finke J

Comparison of gel versus capillary electrophoresis for chimerism monitoring by PCR amplification of microsatellite markers after allogeneic hematopoietic cell transplantation.

BLOOD. 2004 NOV 16; 104 (11): 360B-361B

5444

5444 Nava P, Simon A, Gonzalez-Pardo G, Jimenez JL, Gonzalez-Rivera M, et al.

Anticipated diagnosis of adverse events after stem cell transplantation using highly sensitive STR-PCR for chimerism quantification.

BLOOD. 2004 NOV 16; 104 (11): 361B-361B

5445

5445 Ma SY, Au WY, Lei AKW, Tse E, Chim CS, et al.

Full donor chimerism in both plasma and mononuclear cell after haematopoietic stem cell transplant (HSCT) at D28 is predictive of acute graft-versus-host disease but not disease relapse or graft failure.

BLOOD. 2004 NOV 16; 104 (11): 362B-362B

5446

5446 Tang XW, Wu DP, Sun AN, Zhu ZL, Chang HR, et al.

The application of sequential and quantitative analysis of donor chimerism in adoptive immunotherapy following allogeneic stem cell transplantation.

BLOOD. 2004 NOV 16; 104 (11): 363B-363B

5447

5447 Yoshihara T, Morimoto A, Kuroda H, Ishida H, Imamura T, et al.

Clinical status longer than one year post-transplantation in 4 recipients of non-T-cell-depleted HLA-haploidentical transplantation based on feto-maternal microchimerism.

BLOOD. 2004 NOV 16; 104 (11): 375B-375B

5448

5448 Zeiser R, Spyridonidis A, Waesch R, Ihorst G, Grullich C, et al.

Comparison of conventional versus lineage-specific chimerism analysis for detection of minimal residual disease or relapse in myeloid malignancies after myeloablative allogeneic hematopoietic cell transplantation with respect to clinical follow-up.

BLOOD. 2004 NOV 16; 104 (11): 456A-456A

5449

5449 Wu CJ, Gladwin MT, Krishnamurti L, Biernacki M, Rogers SA, et al.

Mixed chimerism following nonmyeloablative stem cell transplantation for sickle cell disease prevents intravascular hemolysis and restores endothelial function.

BLOOD. 2004 NOV 16; 104 (11): 467A-467A

5450

5450 Michallet M, Le QH, Michallet AS, Nicolini FE, Thiebaut A, et al.

Kinetics of chimerism conversion to total donor profile: Impact on transplant outcome after reduced intensity conditioning allogeneic transplantation.

BLOOD. 2004 NOV 16; 104 (11): 504A-504A

Date / Author / Journal

LCS

GCS

LCR

5451

5451 Kahl C, Mielcarek M, Iwata M, Harkey M, Storer B, et al.

Radiation dose determines degree of donor chimerism after nonmyeloablative hematopoietic cell transplantation.

BLOOD. 2004 NOV 16; 104 (11): 506A-506A

5452

5452 Burt RK, Verda L, Kim DA, Statkute L, Oyama Y, et al.

Embryonic stem cell transplant (ESCT)-derived mixed hematopoietic chimerism prevents diabetes in NOD mice.

BLOOD. 2004 NOV 16; 104 (11): 587A-587A

5453

5453 Spyridonidis A, Metaxas Y, Zeiser R, Waterhouse M, Faber P, et al.

Allogeneic hematopoietic stem cell transplantation (HSCT) is followed by epithelial chimerism of the oral mucosal

BLOOD. 2004 NOV 16; 104 (11): 737A-737A

5454

5454 Baron F, Maris M, Storer B, Sandmaier B, Panse J, et al.

Higher doses of transplanted CD34+, CD3+ and CD8+ cells are associated with better donor T-cell chimerism and less graft rejection, but not with GVHD after nonmyeloablative conditioning for unrelated hematopoietic cell transplantation.

BLOOD. 2004 NOV 16; 104 (11): 753A-753A

5455

5455 Kaltwasser M, Lehne M, Wajant H, Huber C, Hartwig UF

Separation of GvH- and GvL-Immune responses in allogeneic stem cell transplantation by CD95-mediated depletion of alloreactive T-cells using CD178 based proapoptotic chimeric molecules.

BLOOD. 2004 NOV 16; 104 (11): 834A-834A

5456

5456 Sokolic RA, Gu YC, Burkholder T, Tuschong LM, Hai M, et al.

Non-myeloablative conditioning with busulfan prior to allogeneic hematopoietic stem cell transplant results in mixed chimerism and reversal of the phenotype in canine leukocyte adhesion deficiency with minimal regimen related toxicity and without graft-vs.-host disease.

BLOOD. 2004 NOV 16; 104 (11): 837A-837A

5457

5457 Bailo M, Soncini M, Vertua E, Signoroni PB, Sanzone S, et al.

Engraftment potential of human amnion and chorion cells derived from term placenta

TRANSPLANTATION. 2004 NOV 27; 78 (10): 1439-1448

5458

5458 Jiang SG, Walker L, Afentoulis M, Anderson DA, Jauron-Mills L, et al.

Transplanted human bone marrow contributes to vascular endothelium

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2004 NOV 30; 101 (48): 16891-16896

5459

5459 Petersen S, Gendelman M, Murphy K, Torbenson M, Jones R, et al.

Microchimerism following canine in utero hematopoietic stem cell transplantation: Development of T-cell dosing regimens

AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY. 2004 DEC; 191 (6): S15-S15

5460

5460 Mengel M, Jonigk D, Wilkens L, Radermacher J, von Wasielewski R, et al.

Chimerism of metanephric adenoma but not of carcinoma in kidney transplants

AMERICAN JOURNAL OF PATHOLOGY. 2004 DEC; 165 (6): 2079-2085

Date / Author / Journal

5461

Reminiscences of Sir Peter Medawar: In hope of antigen-specific transplantation tolerance

AMERICAN JOURNAL OF TRANSPLANTATION. 2004 DEC; 4 (12): 1937-1940

5462

5462 Blaney JE, Hanson CT, Firestone CY, Hanley KA, Murphy BR, et al.

Genetically modified, live attenuated dengue virus type 3 vaccine candidates

AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE. 2004 DEC; 71 (6): 811-821

5463

5463 Febbraio M, Guy E, Silverstein RL

Stem cell transplantation reveals that absence of macrophage CD36 is protective against atherosclerosis

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY. 2004 DEC; 24 (12): 2333-2338

5464

5464 Kabl C, Mielcarek M, Iwata M, Harkey MA, Storer B, et al.

Radiation dose determines the degree of myeloid engraftment after nonmyeloablative stem cell transplantation

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION. 2004 DEC; 10 (12): 826-833

5465

5465 Thompson JS, Pomeroy C, Kryscio RJ, Brown SA, Reece D, et al.

Use of a T cell-specific monoclonal antibody, T10B9, in a novel allogeneic stem cell transplantation protocol for hematologic malignancy high-risk patients

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION. 2004 DEC; 10 (12): 858-866

5466

5466 Gupta V, Ball SE, Yi QL, Sage D, McCann SR, et al.

Favorable effect on acute and chronic graft-versus-host disease with cyclophosphamide and in vivo anti-CD52 monoclonal antibodies for marrow transplantation from HLA-identical sibling donors for acquired aplastic anemia

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION. 2004 DEC; 10 (12): 867-876

5467

5467 Mohr B, Koch R, Thiede C, Kroschinsky F, Ehninger G, et al.

CD34+ cell dose, conditioning regimen and prior chemotherapy: factors with significant impact on the early kinetics of donor chimerism after allogeneic hematopoietic cell transplantation

BONE MARROW TRANSPLANTATION. 2004 DEC; 34 (11): 949-954

5468

5468 Au WY, Chan EC, Pang A, Lie AKW, Liang R, et al.

Nonhematologic malignancies after allogeneic hematopoietic stem cell transplantation: incidence and molecular monitoring

BONE MARROW TRANSPLANTATION. 2004 DEC; 34 (11): 981-985

5469

5469 Ho VT, Kim HT, Li S, Hochberg EP, Cutler C, et al.

Partial CD8+ T-cell depletion of allogeneic peripheral blood stem cell transplantation is insufficient to prevent graft-versus-host disease

BONE MARROW TRANSPLANTATION. 2004 DEC; 34 (11): 987-994

5470

5470 Passweg JR, Orchard K, Buergi A, Gratwohl A, Powles R, et al.

Autologous/syngeneic stem cell transplantation to treat refractory GvHD

BONE MARROW TRANSPLANTATION. 2004 DEC; 34 (11): 995-998

Date / Author / Journal

LCS

GCS

LCR

5471

5471 Alessandrino EP, Bernasconi P, Colombo AA, Caldera D, Malcovati L, et al.

Reduced-intensity conditioning regimen with thiotepa and fludarabine followed by allogeneic blood stem cell transplantation in haematological malignancies

BONE MARROW TRANSPLANTATION. 2004 DEC; 34 (12): 1039-1045

5472

5472 Koldehoff M, Beelen DW, Trenschel R, Steckel NK, Peceny R, et al.

Outcome of hematopoietic stem cell transplantation in patients with atypical chronic myeloid leukemia

BONE MARROW TRANSPLANTATION. 2004 DEC; 34 (12): 1047-1050

5473

5473 Matsuda K, Yamauchi K, Tozuka M, Suzuki T, Sugano M, et al.

Monitoring of hematopoietic chimerism by short tandem repeats, and the effect of CD selection on its sensitivity

CLINICAL CHEMISTRY. 2004 DEC; 50 (12): 2411-2414

5474

5474 Walshe J, Bishop MR

Factors affecting engraftment of allogeneic hematopoietic stem cells after reduced-intensity conditioning

CYTOTHERAPY. 2004 DEC; 6 (6): 589-592

5475

5475 Cho SG, Shuto Y, Soda Y, Nakazaki Y, Izawa K, et al.

Anti-NK cell treatment induces stable mixed chimerism in MHC-mismatched, T cell-depleted, nonmyeloablative bone marrow transplantation

EXPERIMENTAL HEMATOLOGY. 2004 DEC; 32 (12): 1246-1254

5476

5476 Goebel WS, Pech NK, Meyers JL, Srour EF, Yoder MC, et al.

A murine model of antimetabolite-based, submyeloablative conditioning for bone marrow transplantation: biologic insights and potential applications

EXPERIMENTAL HEMATOLOGY. 2004 DEC; 32 (12): 1255-1264

5477

5477 Villaron EM, Almeida J, Lopez-Holgado N, Alcoceba M, Sanchez-Abarca LI, et al.

Mesenchymal stem cells are present in peripheral blood and can engraft after allogeneic hematopoietic stem cell transplantation

HAEMATOLOGICA. 2004 DEC; 89 (12): 1421-1427

5478

5478 Kai T, Kimura H, Shiga Y, Mineishi S, Yoshihara S, et al.

Philadelphia chromosome-positive acute lymphoblastic leukemia rescued with a second allogeneic stem cell transplantation from a haploidentical mother after relapse following cord blood transplantation

INTERNATIONAL JOURNAL OF HEMATOLOGY. 2004 DEC; 80 (5): 453-457

5479

5479 Toubo T, Suga N, Ohga S, Nomura A, Onoe Y, et al.

INTERNATIONAL JOURNAL OF HEMATOLOGY. 2004 DEC; 80 (5): 458-462

5480

5480 Tanaka T, Matsubara H, Adachi S, Chang H, Fujino H, et al.

Second transplantation from HLA 2-loci-mismatched mother for graft failure due to hemophagocytic syndrome after cord blood transplantation

INTERNATIONAL JOURNAL OF HEMATOLOGY. 2004 DEC; 80 (5): 467-469

Date / Author / Journal

LCS

GCS

LCR

5481

5481 Sonnenday CJ, Warren DS, Cooke SK, Dietz HC, Montgomery RA

A novel chimeric ribozyme vector produces potent inhibition of ICAM-1 expression on ischemic vascular endothelium

JOURNAL OF GENE MEDICINE. 2004 DEC; 6 (12): 1394-1402

5482

5482 Khorshid O, Hosing C, Bibawi S, Ueno N, Reveille J, et al.

Nonmyeloablative stem cell transplant in a patient with advanced systemic sclerosis and systemic lupus erythematosus

JOURNAL OF RHEUMATOLOGY. 2004 DEC; 31 (12): 2513-2516

5483

5483 Doyle AM, Lechler RI, Turka LA

Organ transplantation: Halfway through the first century

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. 2004 DEC; 15 (12): 2965-2971

5484

5484 Stevens AM, McDonnell WM, Mullarkey ME, Pang JM, Leisenring W, et al.

Liver biopsies from human females contain male hepatocytes in the absence of transplantation

LABORATORY INVESTIGATION. 2004 DEC; 84 (12): 1603-1609

5485

5485 Scheffold C, Kroeger M, Zuehlsdorf M, Tchinda J, Silling G, et al.

Prediction of relapse of acute myeloid leukemia in allogeneic transplant recipients by marrow CD34+donor cell chimerism analysis

LEUKEMIA. 2004 DEC; 18 (12): 2048-2050

5486

5486 Subklewe M, Nagy M, Schoch C, Jenisch S, Siebert R, et al.

Extramedullary manifestation of a donor-derived acute myeloid leukemia in a liver transplant patient

LEUKEMIA. 2004 DEC; 18 (12): 2050-2053

5487

5487 Miyakoshi S, Kami M, Kishi Y, Murashige N, Yuji K, et al.

Fatal hepatic failure associated with graft rejection following reduced-intensity stem-cell transplantation for chronic idiopathic myelofibrosis (CIMF)

LEUKEMIA & LYMPHOMA. 2004 DEC; 45 (12): 2513-2516

5488

5488 Demir Y, Ozmen S, Klimczak A, Mukherjee AL, Siemionow M

Tolerance induction in composite facial allograft transplantation in the rat model

PLASTIC AND RECONSTRUCTIVE SURGERY. 2004 DEC; 114 (7): 1790-1801

5489

5489 Van de Wiele C, Revets H, Mertens N

Radioimmunoimaging - Advances and prospects

QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING. 2004 DEC; 48 (4): 317-325

5490

5490 Schoeberlein A, Schatt S, Troeger C, Surbek D, Holzgreve W, et al.

Engraftment kinetics of human cord blood and murine fetal liver stem cells following in utero transplantation into immunodeficient mice

STEM CELLS AND DEVELOPMENT. 2004 DEC; 13 (6): 677-684

Date / Author / Journal

LCS

GCS

LCR

5491

5491 Burkhart C, Heusser C, Morris RE, Raulf F, Weckbecker G, et al.

Pharmacodynamics in the development of new immunosuppressive drugs

THERAPEUTIC DRUG MONITORING. 2004 DEC; 26 (6): 588-592

5492

5492 Flesland O, Ip LSK, Storlien AS, Spurkland A, Larsen J, et al.

Microchimerism in immune competent patients related to the leukocyte content of transfused red blood cell concentrates

TRANSFUSION AND APHERESIS SCIENCE. 2004 DEC; 31 (3): 173-180

5493

5493 Chen J, He QZ, Xu HB, Su LP, Zhang JP, et al.

The CD28 peptidemimic can induce mixed chimerism and prolong the survival of cardiac allografts

TRANSPLANT IMMUNOLOGY. 2004 DEC; 13 (4): 283-288

5494

5494 Tsutsumi Y, Tanaka J, Minami H, Musashi M, Fukushima A, et al.

Monitoring of T-cell repertoire was useful for predicting graft-versus-host disease prognosis in a patient with chronic myelogeneous leukemia after allogeneic bone marrow transplantation

TRANSPLANTATION PROCEEDINGS. 2004 DEC; 36 (10): 3200-3202

5495

5495 Kanatani T, Wright B, Lanzetta M, Molitor M, McCaughan GW, et al.

Experimental limb transplantation, Part III: Induction of tolerance in the rigorous strain combination of Brown Norway donor to Lewis recipient

TRANSPLANTATION PROCEEDINGS. 2004 DEC; 36 (10): 3276-3282

5496

5496 Ichinohe T, Uchiyama T, Shimazaki C, Matsuo K, Tamaki S, et al.

Feasibility of HLA-haploidentical hematopoletic stem cell transplantation between noninherited maternal antigen (NIMA)-mismatched family members linked with long-term fetomatemal microchimerism

BLOOD. 2004 DEC 1; 104 (12): 3821-3828

5497

5497 Tykodi SS, Warren EH, Thompson JA, Riddell SR, Childs RW, et al.

Allogeneic hematopoietic cell transplantation for metastatic renal cell carcinoma after nonmyeloablative conditioning: Toxicity, clinical response, and immunological response to minor histocompatibility antigens

CLINICAL CANCER RESEARCH. 2004 DEC 1; 10 (23): 7799-7811

5498

5498 Metzler B, Gfeller P, Bigaud M, Li JP, Wieczorek G, et al.JOURNAL OF IMMUNOLOGY. 2004 DEC 1; 173 (11): 7025-7036

5499

5499 Morris E, Thomson K, Craddock C, Mahendra P, Milligan D, et al.

Outcomes after alemtuzumab-containing reduced-intensity allogeneic transplantation regimen for relapsed and refractory non-Hodgkin lymphoma

BLOOD. 2004 DEC 15; 104 (13): 3865-3871

171

5500

5500 Krause DS, Van Etten RA

Adoptive immunotherapy of BCR-ABL-induced chronic myeloid leukemia-like myeloproliferative disease in a murine model

BLOOD. 2004 DEC 15; 104 (13): 4236-4244

Chimerism and Transplantation topic search 8998 papers downloaded from Web of Science. Topic=((chimer* OR microchimer) AND (graft OR allograft* OR homograft* OR transplant*)) Timespan=1950-01-01 - 2011-12-31. Databases=SCI-EXPANDED, SSCI, A&HCI. Lemmatization=Off AND 85 papers added from the cited references list.	Historiographs	Glossary HistCite Guide About Grand Totals: LCS 52148, GCS 386809, CR 295585 Collection span: 1945 - 2011
List of All Records